Cellular association and cytotoxicity of doxorubicin-loaded immunoliposomes targeted via Fab' fragments of an anti-CD74 antibody

Drug Delivery

Volumn 14, Issue 3, 2007, Pages 171-175

  Lundberg, B B ^a   Griffiths, G ^b   Hansen, H J ^b  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

^b IMMUNOMEDICS INC   (United States)

Author keywords

B cell Lymphoma; Doxorubicin; Fab' Fragments of Anti CD74; Immunoliposomes; Targeted Drug Delivery

Indexed keywords

DOXORUBICIN; IMMUNOLIPOSOME;

ARTICLE; BIOACCUMULATION; CYTOTOXICITY; GENE TARGETING; LYMPHOMA CELL; NITROBLUE TETRAZOLIUM TEST; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAJI CELL; SURFACE PROPERTY;

ANTIBIOTICS, ANTINEOPLASTIC; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CELL LINE; CELL SURVIVAL; DOXORUBICIN; EXCIPIENTS; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOCHEMISTRY; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN G; KINETICS; LIPOSOMES;

EID: 34247536266     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540601036831     Document Type: Article

References (19)

1. Allen, T. M. 1994. The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system. Adv. Drug Del. Rev. 13:285-309.
2. Bally, M. B., Lim, H., Cullis, P. R., and Mayer, L. D. 1998. Controlling the drug delivery attributes of lipid-based drug formulations. J. Liposome Res. 8:299-335.
3. Bolotin, E. M., Cohen, R., Bar, L. K., Emanuel, S. N., Lasic, D. D., and Barenholz, Y. 1994. Ammonium sulfate gradients for efficient and stable remote loading of amphipathic weak bases into liposomes and ligandosomes. J. Liposome Res. 4:455-479.
4. 2 immunoliposomes entrapping doxorubicin for experimental therapy of human neuroblastoma. Cancer Lett. 197:199-204.
5. Drummond, D. C., Zignani, M., and Leroux, J. 2000. Current status of pHsensitive liposomes in drug delivery. Prog. Lipid Res. 39:409-460.
6. Griffiths, G. L., Mattes, M. J., Stein, R., Govindan, S. V., Horak, I. D., Hansen, H. J., and Goldenberg, D. M. 2003. Cure of SCID mice bearing human Blymphoma xenografts by an anti-CD74 antibody-anthracycline drug conjugate. Clin. Cancer Res. 9:6567-6571.
7. Hansen, H. J., Ong, G. L., Diril, H., Valdez, A., Roche, P. A., Griffiths, G. L., Goldenberg, D. M., and Mattes, M. J. 1996. Internalization and catabolism of radiolabelled antibodies to the MHC class-II invariant chain by B-cell lymphomas. Biochem. J. 320:293-300.
8. Lopes de Menezes, D. E., Kierchmeier, M. J., Gagne, J.-F., Pilarski, L. M., and Allen, T. M. 1999. Cellular trafficking and cytotoxicity of anti-CD19-targeted liposomal doxorubicin in B lymphoma cells. J. Liposome Res. 9:199-228.
9. Lopes de Menezes, D. E., Pilarski, L. M., and Allen, T. M. 1998. In vivo and in vitro targeting of immunoliposomal doxorubicin to human B-cell lymphoma. Cancer Res. 58:3320-3330.
10. Lundberg, B. B., Griffiths, G., and Hansen, H. J. 2004. Cellular association and cytotoxicity of anti-CD74-targeted lipid drug-carriers in B lymphoma cells. J. Control. Rel. 94:155-161.
11. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65:55-63.
12. Muggia, F., Hainsworth, J. D., Jeffers, S., Miller, P., Groshen, S., Tan, M., and Roman, L. 1997. Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation. J. Clin. Oncol. 15:987-993.
13. Northfelt, D. W., Martin, F. J., Working, P., Volberding, P. A., Russel, J., Newman, M., Amantea, M. A., and Kaplan, L. D. 1996. Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol. Pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma. J. Clin. Pharmacol. 36:55-63.
14. 90Yttrium. Clin. Cancer Res. 7:1505-1510.
15. Olson, F., Hunt, C. A., Szoka, F. C., and Wail, W. J. 1979. Preparation of liposomes of defines size distribution by extrusion through polycarbonate membranes. Biochim. Biophys. Acta 557:9-23.
16. Papahadjopoulos, D., Kirpotin, D. K., Park, J. W., Hong, K., Shao, Y., Shalaby, R., Colbert, G., and Benz, C. C. 1998. Targeting of drugs to solid tumors using anti-HER2 immunoliposomes. J. Liposome Res. 8:425-442.
17. Sapra, P., Moase, E. H., Ma, J., and Allen, T. M. 2004. Improved therapeutic response in a xenograft model of human B lymphoma (Namalwa) for liposomal vincristine versus liposomal doxorubicin targeted via anti-CD19 Ig2a or Fab' fragments. Clin. Cancer Res. 10:1100-1111.
18. Sugano, M., Egilmez, N. K., Yokota, S. J., Chen, F. A., Harding, J., Huang, S. K., and Bankert, R. B. 2000. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice. Cancer Res. 60:6942-6949.
19. Zalipsky, S., Hansen, C. B., Lopes de Menezes, D. E., and Allen, T. M. 1996. Long-circulating, poyethylene glycol-grafted immunoliposomes. J. Control. Rel. 39:153-161.